Chemoinformaics analysis of 2-Hydroxy-4-methoxybenzaldehyde
| Molecular Weight | 152.149 | nRot | 2 |
| Heavy Atom Molecular Weight | 144.085 | nRig | 7 |
| Exact Molecular Weight | 152.047 | nRing | 1 |
| Solubility: LogS | -1.855 | nHRing | 0 |
| Solubility: LogP | 1.798 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 21.1003 |
| nHD | 1 | BPOL | 10.6297 |
| QED | 0.648 |
| Synth | 1.951 |
| Natural Product Likeliness | 0.618 |
| NR-PPAR-gamma | 0.201 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.014 |
| HIA | 0.01 |
| CACO-2 | -4.465 |
| MDCK | 0.0000109 |
| BBB | 0.721 |
| PPB | 0.816249 |
| VDSS | 0.969 |
| FU | 0.141192 |
| CYP1A2-inh | 0.909 |
| CYP1A2-sub | 0.837 |
| CYP2c19-inh | 0.278 |
| CYP2c19-sub | 0.382 |
| CYP2c9-inh | 0.077 |
| CYP2c9-sub | 0.918 |
| CYP2d6-inh | 0.072 |
| CYP2d6-sub | 0.859 |
| CYP3a4-inh | 0.078 |
| CYP3a4-sub | 0.239 |
| CL | 9.643 |
| T12 | 0.781 |
| hERG | 0.022 |
| Ames | 0.432 |
| ROA | 0.054 |
| SkinSen | 0.477 |
| Carcinogencity | 0.257 |
| EI | 0.992 |
| Respiratory | 0.945 |
| NR-Aromatase | 0.02 |
| Antiviral | No |
| Prediction | 0.856744 |